Trial description:
Prospective registry of Sentinel Node (SN) positive melanoma patients with minimal SN tumor burden who undergo Completion Lymph Node Dissection (CLND) or Nodal Observation
Contact name:
Dr Amer Durrani
Trial start date:
Thursday, October 19, 2017
Trial end date:
Saturday, May 1, 2021
Trial tumour type:
Skin & melanoma
Show on Radiotherapy:
No
